Ligand validation:6GDO

EVZ: methyl 1-[4-[(2-azanyl-1,3-benzothiazol-6-yl)sulfanylmethyl]phenyl]carbonylpiperidine-4-carboxylate

EVZ is a Ligand Of Interest in 6GDO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6GDO_EVZ_D_302	78%	15%	0.107	0.948	1.9	1.87	8	8	0	0	100%	0.8
6GDO_EVZ_A_302	68%	15%	0.09	0.953	2.23	1.57	5	7	0	0	70%	0.56
6GDO_EVZ_B_302	59%	17%	0.101	0.935	2.47	1.21	6	2	0	0	70%	0.56

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.